Consolidated Statements of Income - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2015	Jul. 31, 2014	Jul. 31, 2015	Jul. 31, 2014
Revenues
Revenues	$ 3,244,075	$ 2,865,319	$ 9,229,586	$ 8,574,311
Cost and expenses:
Cost of revenues	1,296,796	1,300,968	3,803,288	3,989,402
Research and development expenses	185,550	171,325	553,924	506,604
Selling, general, and administrative expenses	1,670,334	1,168,614	4,078,973	3,468,094
Total costs and expenses	3,152,680	2,640,907	8,436,185	7,964,100
Income from operations	91,395	224,412	793,401	610,211
Interest expense - related party	54,285	59,262	170,875	180,063
Income before income taxes	37,110	165,150	622,526	430,148
Provision for Income taxes	14,690	36,408	307,050	156,502
Net income	$ 22,420	$ 128,742	$ 315,475	$ 273,646
Net income per common share - basic		$ 0.02	$ 0.04	$ 0.04
Net income per common share - diluted		$ 0.02	$ 0.04	$ 0.04
Weighted average number of common shares outstanding - basic	7,630,482	7,529,026	7,647,066	7,433,951
Weighted average number of common shares outstanding - diluted	7,753,176	7,812,157	7,769,760	7,713,440